2023年FDA批准的精神药物药物
Ahmed Naguy1, Nadyah Alayadhi2, Saxby Pridmore3
1Al-Manara CAP Centre, Kuwait Centre for Mental Health (KCMH), Jamal Abdul-Nassir St, Shuwaikh, Kuwait.
Asian journal of psychiatry
|June 28, 2023
概括
美国FDA于2023年6月批准了新的精神药物,为心理药物治疗提供了新的治疗方法. 这一更新有助于临床医生了解精神病药物治疗的最新进展.
科学领域:
- 精神病学和药理学 精神病学和药理学
- 神经科学与药物开发
背景情况:
- 心理药物治疗的景观正在不断发展.
- 了解新药批准的情况对于有效的临床实践至关重要.
研究的目的:
- 总结一下2023年6月美国FDA最近批准的精神药物药物.
- 为忙碌的临床医生提供关于创新的精神药物治疗方案的简短更新.
主要方法:
- 对FDA药物批准公告的审查.
- 新批准的精神药物药物的汇编.
主要成果:
- 几种新型精神药物已经获得了FDA的批准.
- 这些批准代表了治疗各种精神疾病的潜在进展.
结论:
- 最近的FDA批准为心理药理学提供了新的治疗途径.
- 临床医生应该熟悉这些新兴的治疗选择,以优化患者的护理.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
279
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
279
Drug Therapy
74
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
74
Psychosis and Antipsychotic Drugs: Overview
348
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
348
Psychosis: Goals of Pharmacotherapy
171
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
171
Antipsychotic Drugs: Typical and Atypical Agents
263
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
263
Mania and Antimanic Drugs: Overview
253
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
253


